Biologic Drug Product CDMO Benchmarking (3rd Ed.)


ISR’s Biologic Drug Product Contract Manufacturing Quality Benchmarking (3rd Edition) report brings with it a wealth of knowledge and information created with two goals in mind, help biopharmaceutical companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 23 performance attributes specific to outsourced drug product manufacturing. In this Consumer Reports-style analysis, ISR presents data on 524 service encounters from 134 respondents who have been involved in outsourced drug product projects in the past 18 months.


Biologic Drug Product Contract Manufacturer Quality Benchmarking (3rd Edition) cover

Drug developers:

  • Make a more educated purchase of CMO services by understanding which manufacturers best fit your company’s needs in addition to how individual CMOs have measured up to sponsor-peer expectations on similar projects
  • Uncover which CMO attributes drive outsourcing partner selection for outsourced biologic drug product manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peers
  • Gain insight into CMO customer loyalty, an index based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience

Contract Manufacturers:

  • Understand your company’s competitive positioning as well as delivery strengths and weaknesses and use this information to develop targeted messaging on true areas of strength
  • Compare your company’s performance against its competitors across 23 performance metrics specific to outsourced drug product manufacturing and related services
  • Gain insight into drug developers’ outsourcing preferences and practices with respect to CMO selection and CMO preference for outsourced biologic drug product manufacturing
  • Outsourcing Philosophies and Practices
  • CMO Selection Drivers
  • CMO Perceptions and Interactions
  • CMO Performance and Loyalty
  • Biologic Drug Product CMO Competitive Landscape
  • Company Service Quality Profiles
  • Study Data
  • Demographics

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at

Biologic Drug Product Benchmarking 2020 sample data

Outsourcing Philosophies and Practices

Primary Section Takeaways
Outsourced Manufacturing Activities
Outsourcing Drivers
Outsourcing Drivers by Company Size
Outsourcing Models
Preferred Providers
Number of Preferred Providers

CMO Selection Drivers

Primary Section Takeaways
Most Important CMO Attributes
CMO Attributes Gaining Importance

CMO Perceptions and Interactions

Primary Section Takeaways
CMO Familiarity
CMO Leaders—Unprompted
CMO Leaders—Prompted
Received Proposals
CMO Preference
CMO Preference Among Users
CMO Cost Perceptions
Summary Table

CMO Performance and Loyalty

Primary Section Takeaways
A Note on Performance Calculations
Performance Across Service Providers
Figure 1 – CMO Performance: Delivery Factors
Figure 2 – CMO Performance: Organization Factors
Figure 3 – CMO Performance: Capabilities Ratings
Figure 4 – CMO Performance: Staff Characteristics
Figure 5 – CMO Performance: Service Capabilities
CMO Loyalty
CMO Loyalty: 3-Year Rolling Average

Biologic Drug Product CMO Competitive Landscape

Company Service Quality Profiles

Study Data

Outsourced Manufacturing Activities
Outsourcing Drivers
Outsourcing Models
Use of Preferred Providers
Number of Preferred Providers
Large Molecule Product Offering
Large vs. Small Molecule Outsourcing
CMO Selection Attributes
CMO Selection Attributes Gaining Importance
CMO Leaders—Unprompted
Other Responses 1%
CMO Familiarity
CMO Leaders—Prompted
Received Proposals
CMO Preference
CMO Cost Perceptions
CMO Drill-downs

3M Drug Delivery Systems
AbbVie Contract Manufacturing
Aji Bio-Pharma
Avid Bioservices
Batavia Biosciences
Baxter BioPharma Solutions
Berkshire Sterile Manufacturing
Boehringer Ingelheim
Brammer Bio
CEPiA Sanofi
Cognate Bioservices
Dalton Pharma Services
Dr. Reddy’s CPS
Emergent Biosolutions
GSK Contract Manufacturing
IDT Biologika
Jubilant HollisterStier
LSNE Contract Manufacturing
Millipore Sigma
Nitto Avecia Pharma Services
Paragon Gene Therapy
Pfizer CentreOne
Piramal Pharma Solutions
Samsung BioLogics
Therapure Biopharma
Wuxi Biologics

CMO Satisfaction Rating Explanations


Company Type
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Biologic Drug Product Outsourcing
Contract Manufacturing Responsibilities
Involvement in Outsourced Manufacturing
Contract Manufacturing Involvement
Years of Industry Experience

Additional information


, ,